(Q45292699)

English

Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's disease

scientific article published in January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6494025

Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's disease (English)

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6494025

Huntington's disease

0 references

0 references

Ferdinando Squitieri

1

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6494025

Milena Cannella

2

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6494025

Claudio Colonnese

8

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6494025

author name string

Maria Simonelli

3

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6494025

Jenny Sassone

4

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6494025

Tiziana Martino

5

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6494025

Eugenio Venditti

6

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6494025

Andrea Ciammola

7

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6494025

Luigi Frati

9

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6494025

Andrea Ciarmiello

10

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6494025

publication date

1 January 2009

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6494025

CNS Neuroscience & Therapeutics

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6494025

15

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6494025

1

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6494025

1-11

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6494025

Onset and rate of striatal atrophy in preclinical Huntington disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00068.X

21 January 2018

Early and progressive accumulation of reactive microglia in the Huntington disease brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00068.X

21 January 2018

Clinical markers of early disease in persons near onset of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00068.X

21 January 2018

Rate of functional decline in Huntington's disease. Huntington Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00068.X

21 January 2018

Factors associated with slow progression in Huntington's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00068.X

21 January 2018

Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2008.00068.X

21 January 2018

Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Automated segmentation and measurement of global white matter lesion volume in patients with multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Family and molecular data for a fine analysis of age at onset in Huntington disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The distribution of structural neuropathology in pre-clinical Huntington's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brain atrophy and lesion load in a large population of patients with multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The association of CAG repeat length with clinical progression in Huntington disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microglial activation correlates with severity in Huntington disease: a clinical and PET study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased rate of whole-brain atrophy over 6 months in early Huntington disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microglial activation in presymptomatic Huntington's disease gene carriers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Visualisation and quantification of rates of atrophy in Alzheimer's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unified Huntington's disease rating scale: Reliability and consistency

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unsupervised, automated segmentation of the normal brain using a multispectral relaxometric magnetic resonance approach.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19228174

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1755-5949.2008.00068.X

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6494025

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6494025

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

2 July 2019

http://europepmc.org/abstract/PMC/6494025

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45292699&oldid=2074043922"